BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32433524)

  • 1. Multi-omic signatures identify pan-cancer classes of tumors beyond tissue of origin.
    González-Reymúndez A; Vázquez AI
    Sci Rep; 2020 May; 10(1):8341. PubMed ID: 32433524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omic tumor data reveal diversity of molecular mechanisms that correlate with survival.
    Ramazzotti D; Lal A; Wang B; Batzoglou S; Sidow A
    Nat Commun; 2018 Oct; 9(1):4453. PubMed ID: 30367051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis.
    Zou J; Du K; Li S; Lu L; Mei J; Lin W; Deng M; Wei W; Guo R
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.
    Naderi A
    Chromosome Res; 2020 Dec; 28(3-4):307-330. PubMed ID: 32816122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOJAH: NOt Just Another Heatmap for genome-wide cluster analysis.
    Rupji M; Dwivedi B; Kowalski J
    PLoS One; 2019; 14(3):e0204542. PubMed ID: 30921318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.
    Johann PD; Altendorf L; Efremova EM; Holsten T; Steinbügl M; Nemes K; Eckhardt A; Kresbach C; Bockmayr M; Koch A; Haberler C; Antonelli M; DeSisto J; Schuhmann MU; Hauser P; Siebert R; Bens S; Kool M; Green AL; Hasselblatt M; Frühwald MC; Schüller U
    Acta Neuropathol; 2023 Sep; 146(3):527-541. PubMed ID: 37450044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of metabolism-associated molecular subtype in ovarian cancer.
    Liu X; Wu A; Wang X; Liu Y; Xu Y; Liu G; Liu L
    J Cell Mol Med; 2021 Oct; 25(20):9617-9626. PubMed ID: 34523782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
    Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
    BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
    Chang WH; Lai AG
    BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiomics approach showing genome-wide copy number alterations and differential gene expression in different types of North-Indian pediatric brain tumors.
    Singh N; Sahu DK; Mishra A; Agarwal P; Goel MM; Chandra A; Singh SK; Srivastava C; Ojha BK; Gupta DK; Kant R
    Gene; 2016 Feb; 576(2 Pt 2):734-42. PubMed ID: 26456192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calling Chromosome Alterations, DNA Methylation Statuses, and Mutations in Tumors by Simple Targeted Next-Generation Sequencing: A Solution for Transferring Integrated Pangenomic Studies into Routine Practice?
    Garinet S; Néou M; de La Villéon B; Faillot S; Sakat J; Da Fonseca JP; Jouinot A; Le Tourneau C; Kamal M; Luscap-Rondof W; Boeva V; Gaujoux S; Vidaud M; Pasmant E; Letourneur F; Bertherat J; Assié G
    J Mol Diagn; 2017 Sep; 19(5):776-787. PubMed ID: 28826610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
    PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic comparison of copy number alterations in four types of female cancer.
    Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
    BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive molecular biomarker identification in breast cancer brain metastases.
    Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
    J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
    Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
    BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
    Naderi A
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Multiple "-omics" Data Reveal Subtypes of Hepatocellular Carcinoma.
    Liu G; Dong C; Liu L
    PLoS One; 2016; 11(11):e0165457. PubMed ID: 27806083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of genome scale data for identifying new players in colorectal cancer.
    Sokolova V; Crippa E; Gariboldi M
    World J Gastroenterol; 2016 Jan; 22(2):534-45. PubMed ID: 26811605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.